Laya Ekhlaspour

MD

Pediatric endocrinologist
Physician-scientist tackling type 1 diabetes with technology

About me

Pronouns: She | Her | Hers

Dr. Laya Ekhlaspour is a pediatric endocrinologist who cares for children with conditions related to the body's hormones, including type 1 and type 2 diabetes. She has a special interest in using technology to help control blood sugar levels and make living with diabetes easier.

Ekhlaspour's research focuses on developing and testing new ways to manage diabetes, including continuous glucose monitors and automated insulin delivery systems, and on new insulin therapies. She received a grant from the National Institutes of Health to study how automating insulin administration could improve blood sugar control after meals.

Originally from Iran, Ekhlaspour earned her medical degree at Kerman University of Medical Sciences in Iran. She completed a residency in pediatrics at the Icahn School of Medicine at Mount Sinai, followed by a fellowship in pediatric endocrinology at Harvard Medical School and Massachusetts General Hospital.

Ekhlaspour is a member of the American Diabetes Association, Endocrine Society, Pediatric Endocrine Society and Iranian American Medical Association.

Education

Kerman University of Medical Sciences, MD, 2006
Residencies

Icahn School of Medicine at Mount Sinai, Pediatrics, 2012
Fellowships

Harvard Medical School, Massachusetts General Hospital, Pediatric Endocrinology, 2016
Academic Title

Assistant Professor

My goal is to support families with diabetes by empowering them to use technologies that make managing the condition easier.

Where I see patients (2)

Selected research

See all research

Corrigendum to "New therapies towards a better glycemic control in youths with type 1 diabetes" [Pharmacol. Res. 2023 Aug 3;195:106882].
Pharmacological research
February 2024
Learn more
Patient reported outcomes (PROs) and user experiences of young children with type 1 diabetes using t:slim X2 insulin pump with control-IQ technology.
Diabetes research and clinical practice
January 2024
Learn more
The Minimally-Invasive Oral Glucose Minimal Model: Estimation of Gastric Retention, Glucose Rate of Appearance, and Insulin Sensitivity from Type 1 Diabetes Data Collected in Real-life Conditions.
IEEE transactions on bio-medical engineering
October 2023
Learn more

Clinical trials

See all clinical trials

Fully Closed Loop at Home (FCL@Home)

The primary metric for analysis will be change in mean sensor glucose value between the second week of the control usual-care period and the one-week remote monitored at-home FCL period.

Recruiting

More about this study

Extended Bolus for Meals in a Closed-loop System

Area under the curve between glucose trace and starting glucose (mg/dL* hour)